US 10233448
Modified double-stranded RNA agents
granted A61PA61P43/00
Quick answer
US patent 10233448 (Modified double-stranded RNA agents) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61P, A61P43/00